Author Guidelines

Author Guidelines

The open-access, peer reviewed, international online Journal Dialogues in Clinical Neuroscience & Mental Health (ISSN 2585-2795), is the official Journal of the non-profit organization “obrela”.

The quarterly issued Journal Dialogues in Clinical Neuroscience & Mental Health (DCNMH) considers the publication of Editorial and Guest Editorials, Review articles, Forefront Reviews, Drug reviews, General articles, Special articles, Original Research articles, as well as of Case Reports, Viewpoints and Letters to the Editor. The editorial board of the journal also has the right to publish the abstracts of Congresses, Seminars etc. The DCNMH does not have page, table or figure restrictions, and authors are encouraged to write complete papers that contain all the data necessary to present their findings persuasively. The DCNMH also features studies that focus on negative results, failure to reproduce, tools and methods, as well as on new theories, models or hypothesis.

Publications of the DCNMH are available to every internet user. Authors remain the copyright holders and grant the community the right to copy, distribute, display, use commercially and make derivative works. The third party (the person who uses the published works) has to give credit to the original author. The DCNMH follows the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (ICJME). Articles submitted for publication should be written in English language. Each paper is typically evaluated by at least two Editors or ad hoc reviewers and is considered for acceptance by the Chief Editor. The copy-editor of the journal has the right to change the language structure of the manuscript without transforming its meaning by the author. Prior to submitting your manuscript, please ensure that it has been prepared according to the guidelines below.

This is an open access journal, which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This Journal is following the Creative Commons license and is in accordance with the BOAI (Open Access Initiative) definition of open access.

Each paper is typically evaluated by at least two Editor or ad hoc reviewers and is considered for acceptance by the Chief Editor.

Submission

Manuscripts may be submitted only by using the online submission system accessible via our website (http://www.obrela-journal.gr). Create a user account, log in and follow the onscreen directions.

Manuscripts

Title page

On the title page provide the title of the article, list each author’s name and institutional affiliation, and indicate the corresponding author. Especially, the first page should include: The title of the manuscript, full names and full postal and e-mail addresses of all authors, the affiliations of the authors by number, and the name, full postal address, including street number and name, and e-mail address of the corresponding author. In addition, provide abbreviations, if relevant, the acknowledgement, and 5-7 key words.

Abstract page

On the abstract page provide the Abstract with no more than 500 words (background, methods, re­sults, conclusions) and 5-7 key-words.

Cover letter

The submitted manuscript must be accompanied by a cover letter which should specify: 1. A statement that the submission is not under consideration by any other journal or published previously (apart from abstracts); 2. A statement by the responsible author certifying that all co-authors have seen and agree with the contents of the manuscript. 3, Full disclosure of the conflict of interest is to be made in the cover letter and manuscript at the time of submission, even if the author judges that it has not influenced the work. If no conflict exists, this must also be stated clearly. All authors should confirm its accuracy.

References

References

References should be sent in numerical and NOT in alphabetical order. In the text, references should be cited by number in soft brackets, e.g. (1-3) (1,2) and must be numbered consecutively. The list of references should be arranged and numbered in order of appearance in the text, not alphabetically. The full titles of the quoted publications should be listed. List only the first six authors followed by “et al.”. The DOI number should be included at the end of the reference. If an article without DOI is included in PubMed, then its PMID number should be reported at the end of the reference. Also, it is necessary the DOI or PMID number at the end of every reference. Examples: (1) Journal article with DOI : Bebbington EP, Freeman D. Transdiagnostic Extension of Delusions: Schizophrenia and Beyond. Schizophr Bull 2017, 43:273–282, doi: 10.1093/schbul/sbw191, (2) Journal article with PMID: Deckersbach T, Savage CR, Phillips KA, Wilhelm S, Buhlmann U, Rauch SL et al. Characteristics of memory dysfunction in body dysmorphic disorder. J Int Neuropsychol Soc 2000, 6:673–681, PMID: 11011514, (3) Chapter in book: Brenner M. Influence of the Social Environment on Psychology: The Historical Perspective. In: Barrett JE (ed) Stress and Mental Disorder. Raven Press, New York, 1979, (4) Book: Kinden A. Stress and emotion. Springer, Berlin, 1990, (5) Article in journal supplement : McKee M, Balabanova D, Basu S, Ricciardi W, Stuckler D. Universal health coverage: a quest for all countries but under threat in some. Value Health 2013, 16(Suppl 1):S39–S45, doi: 10.1016/j.jval.2012.10.001, (6) Presentation in Congress – Abstract book : Silverstone A, Leman H, Stark J. Attempted suicide by drug-overdose. Paper presented at 2nd Congress on Suicide behaviour, 4–6 May 2002. Rome, Abstracts Book, pp 212–213, (7) Webpage : Henry A, Andrews B. Critical issues for parents with mental illness. N.Y. Centre for Mental Health Services 2001 (Cited 2 June 2005). Available from www.mentalorg/publications. Abbreviations of journals should conform to the style used in Index Medicus; journals not indexed there should not be abbreviated.

Figures and Tables

Figures: For reproduction in the journal you will be required, to sup­ply high resolution .tiff images in separate files (1200 dpi for line drawings and 300 dpi for color and half tone work at intended dis­play size – column width of 76 mm or page width of 160 mm). It is advisable to create your high resolution images first as they can easily converted into low resolution images for on line submission. Line drawings, graphs, and charts should be professionally drawn or computer generated and printed on a high resolution laser printer. Any lettering in the figures should be large enough to stand photographic reduction. Authors should prepare their figures for either one column (76 mm) or the entire page width (160 mm). The editors reserve the right to reduce the size of illustrated material. Authors may, however, specifically request a larger reproduction. The author is responsible for obtaining written permission to repro­duce previously published material (illustrations, tables) from the copyright holder. The consent of the senior author must also be ac­quired.

Informed consent statement

For studies involving experimentation with human subjects or tissues, the manuscript should include a statement declaring that informed consent was obtained from the subjects for participation in the study or use of their tissue. Furthermore, in case reports or other studies in which case details, personal information or images are included that may enable an individual to be identified, the individual or a parent, guardian or next of kin must consent to its publication, and this consent should be declared in the manuscript. Authors should disclose to patients that personally identifiable material would be available via the Internet as well as in print after publication (http://www.icmje.org).

Human and Animal rights statement

Research that is performed on humans should follow international and national regulations in
accordance with the Declaration of Helsinki (https://www.wma.net/policies-post/wma-declaration-ofhelsinki-ethical-principles-for-medical-research-involving-human-subjects/) or any other relevant set of ethical principles. With regard to the use of experimental animals, any research performed must follow internationally recognized guidelines on animal welfare, as well as local and national regulations, in accordance with the U.K. Animals (Scientific Procedures) Act and associated guidelines, the EU Directive 2010/63/EU for animal experiments, or the National Institutes of Health guide for the care and use of Laboratory animals. All animal studies should also comply with the ARRIVE guidelines (http://www.nc3rs.org.uk/arrive-guidelines) and the 2013 AVMA euthanasia guidelines. A statement must be included in the Materials and methods section of the manuscript, identifying the institutional and/or licensing committee that has approved the experiments undertaken. Signed proof of this approval from the committee must also be provided.

Proofs

A letter for articles accepted for publication accompanied by the review­ers’ comments is sent to the authors for final corrections. Authors must check their manuscript carefully before submission, after responding to peer- review, and when answering queries raised at the proof stage. Any errors will be faithfully transferred into the final PDF and print versions.

Article charges

The invited articles, as well articles from the collaborative institutions and organizations, may be published free of charge.
For the rest articles, the fees are €200 / £180 / $230.

Τhe article fee is payable on acceptance.

Copyright Notice

Authors who publish with this journal agree to the following terms:

1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (The Effect of Open Access).

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party. All rejected manuscripts will be archived on our journal management system.

CODE OF CONDUCT

For authors

1. i) The research being reported should have been conducted in an ethical and responsible manner and should comply with all relevant legislation.
   ii) Researchers should present their results clearly, honestly, and without fabrication, falsification or inappropriate data manipulation.
   iii) Researchers should strive to describe their methods clearly and unambiguously so that others can confirm their findings.
   iv) Researchers should adhere to publication requirements that submitted work is original, is not plagiarized, and has not been published elsewhere.
   v) Authors should take collective responsibility for submitted and published work.
   vi) The authorship of research publications should accurately reflect individuals’ contributions to the work and its reporting.
   vii) Funding sources and relevant conflicts of interest should be disclosed.

For reviewers

1. i) Only agree to review manuscripts for which they have the subject expertise required to carry out a proper assessment and which they can assess in a timely manner.
   ii) Respect the confidentiality of peer review and not reveal any details of a manuscript or its review, during or after the peer-review  process, beyond those that are released by the journal.
   iii) Not use information obtained during the peer-review process for their own or any other person’s or organization’s advantage, or to disadvantage or discredit others.
   iv) Declare all potential conflicting interests, seeking advice from the journal if they are unsure whether something constitutes a relevant interest.
   v) Not allow their reviews to be influenced by the origins of a manuscript, by the nationality, religious or political beliefs, gender or other characteristics of the authors, or by commercial considerations.
   vi) Be objective and constructive in their reviews, refraining from being hostile or inflammatory and from making libelous or derogatory personal comments.
   vii) Acknowledge that peer review is largely a reciprocal endeavor and undertake to carry out their fair share of reviewing and in a timely manner.
   viii) Provide journals with personal and professional information that is accurate and a true representation of their expertise.
   ix) Recognize that impersonation of another individual during the review process is considered serious misconduct.

For editors

1. i) Editors are accountable and should take responsibility for everything they publish.
   ii) Editors should make fair and unbiased decisions independent from commercial consideration and ensure a fair and appropriate peer review process.
   iii) Editors should adopt editorial policies that encourage maximum transparency and complete, honest reporting.
   iv) Editors should guard the integrity of the published record by issuing corrections and retractions when needed and pursuing suspected or alleged research and publication misconduct.
   v) Editors should pursue reviewer and editorial misconduct.
   vi) Editors should critically assess the ethical conduct of studies in humans and animals.
   vii) Peer reviewers and authors should be told what is expected of them.
   viii) Editors should have appropriate policies in place for handling editorial conflicts of interest.

If the Reviewers have further queries, they may go through the “Instructions to Authors“. They can also use the questions below, when reviewing the manuscripts:

• Please state any conflict(s) of interest that you have in relation to the review of this manuscript (state “none” if this is not applicable).
• Do you suspect any research or publication misconduct? If yes, please indicate in detail.
• Does the manuscript contain new and significant information to justify publication?
• Is the title of the article appropriate?
• Does the abstract clearly and accurately describe the content of the article?
• Is the problem significant and concisely stated?
• Are the methods described comprehensively?
• Is the results section clear and satisfactory?
• Are the interpretations and conclusions justified by the results?
• Is adequate and current reference made to other work in the field?
• Is the language acceptable?
• Please rate the priority for publishing this article (1 is the highest priority, 10 is the lowest priority).
• Is the appropriate terminology used in the text?
• Is it sufficient that figures and/or tables?
• Is it necessary to shorten the article?

Contact

Editorial management & manuscript submission: editor@obrela-journal.gr

Editorial office: Obrela, 2 Erifilis, 11634 Athens, Greece, 0030 210 7290496, info@obrela.gr, www.obrela.gr

Legal support: www.mtboutiquelaw.com, info@mtboutiquelaw.com